Pharmacist-driven outreach initiative to increase prescribing of sodium-glucose cotransporter-2 inhibitors in eligible VHA patients with chronic kidney disease: a study protocol

Patients with chronic kidney disease (CKD) are at increased risk for multiple adverse events, several of which have been proven to be less likely with the use of sodium-glucose cotransporter-2 inhibitors (SGLT...

Source: BMC Nephrology - January 5, 2024 Category: Urology & Nephrology Authors: Deborah L. Pestka, Daniel Murphy, Pearl Huynh, Jessica A. Rechtzigel, Shari Kjos, Lisa Marie Ellich, Adam N. Kaplan, Brent C. Taylor, Melissa Atwood, Beth A. Polsfuss, Joseph Y. Lee and Areef Ishani Tags: Study Protocol Source Type: research